Fifth Lane Capital, LP Reneo Pharmaceuticals, Inc. Call Options Transaction History
Fifth Lane Capital, LP
- $108 Million
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.4MCall Options Held
125KPut Options Held
3.1K-
Nea Management Company, LLC Timonium, MD4.79MShares$7.23 Million0.56% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.53 Million0.61% of portfolio
-
Highbridge Capital Management LLC New York, NY2.74MShares$4.13 Million1.03% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.08 Million0.33% of portfolio
-
River Vest Venture Management LLC St. Louis, MO2.53MShares$3.83 Million51.67% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $37M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...